STEPHANIE HILPERT: Open Payments
NPI 1760584346 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 17 payments from 16 companies in 2025. Trend: 2023 $321 · 2024 $398 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 2 | $68 |
| Celgene Corporation | 1 | $46 |
| Exelixis Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Eisai Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| BeOne Medicines USA, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| PFIZER INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
Products named: REBLOZYL, Quzyttir, CABOMETYX, KEYTRUDA, Xermelo, Lenvima, ORGOVYX, BRUKINSA.
Industry payments across ID — which companies pay providers there.
